chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Lung opacity, Pneumonia viral, Procalcitonin normal, Red blood cell sedimentation rate increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020 , Pfizer, dose #1 01/19/2021 Pfizer, dose #2 08/23 COVID swab, result: detected 08/21 pt cc: cough, dyspnea, fatigue exposure: unknown 08/23 pt admit to medicine cc: General fatigue and shortness of breath dx: Acute hypoxic respiratory failure LOS: 5 days 08/23 CTA PE impression: Negative study for acute pulmonary embolism. Multifocal pneumonia, with the largest opacity in the RIGHT lower lobe. Recommend PA and lateral chest radiographs in 6-8 weeks after appropriate treatment to document resolution. 08/23 CXR impression: No acute pulmonary finding. 08/25 FIBRINOGEN result: 491 08/25DDIMER result: 0.99 08/25 ESR result: 41 08/26 FIBRINOGEN result: 378 08/26 DDIMER result: 0.6 08/26 ESR result: 30 08/27 FIBRINOGEN result: 326 08/27 DDIMER result: 1.56 08/27 ESR result: 21 09/05 pt traveled and was readmitted to a non-Facility hospital LOS: unknown 09/09 COVID-19 ANTIGEN(BINAX) result: not detected 09/09 ESR result: 7 09/09 CTA PE impression: No pulmonary embolus. Since prior CT dated 8/23/2021, some worsening of multifocal airspace and groundglass opacities, consistent with known viral pneumonia, again most pronounced in the right lower lobe. 09/09 BNP result: 106.3 09/09 procalcitonin result: <0.05 09/09 pt admit to cc: General fatigue and shortness of breath dx: COVID Pneumonia LOS: 1 day 09/10 FIBRINOGEN result: 250 09/10 DDIMER result: 1.41 09/10 ESR result: 10
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020 , Pfizer, dose #1 01/19/2021 Pfizer, dose #2 08/23 COVID swab, result: detected 08/21 pt cc: cough, dyspnea, fatigue exposure: unknown 08/23 pt admit to medicine cc: General fatigue and shortness of breath dx: Acute hypoxic respiratory failure LOS: 5 days 08/23 CTA PE impression: Negative study for acute pulmonary embolism. Multifocal pneumonia, with the largest opacity in the RIGHT lower lobe. Recommend PA and lateral chest radiographs in 6-8 weeks after appropriate treatment to document resolution. 08/23 CXR impression: No acute pulmonary finding. 08/25 FIBRINOGEN result: 491 08/25DDIMER result: 0.99 08/25 ESR result: 41 08/26 FIBRINOGEN result: 378 08/26 DDIMER result: 0.6 08/26 ESR result: 30 08/27 FIBRINOGEN result: 326 08/27 DDIMER result: 1.56 08/27 ESR result: 21 09/05 pt traveled and was readmitted to a non-Facility hospital LOS: unknown 09/09 COVID-19 ANTIGEN(BINAX) result: not detected 09/09 ESR result: 7 09/09 CTA PE impression: No pulmonary embolus. Since prior CT dated 8/23/2021, some worsening of multifocal airspace and groundglass opacities, consistent with known viral pneumonia, again most pronounced in the right lower lobe. 09/09 BNP result: 106.3 09/09 procalcitonin result: <0.05 09/09 pt admit to cc: General fatigue and shortness of breath dx: COVID Pneumonia LOS: 1 day 09/10 FIBRINOGEN result: 250 09/10 DDIMER result: 1.41 09/10 ESR result: 10
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Death
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 CXR impression: Probable atelectatic changes in the left base. Otherwise no acute process is seen. 08/26 pt cc: Nausea, vomiting, fatigue exposure: unknown 08/28 pulm v/q impression: No definite perfusion abnormality to suggest significant pulmonary embolus. Small pulmonary emboli cannot be completely excluded. 09/01 CXR impression: New and large-volume parenchymal opacities within both lungs, RIGHT much worse than LEFT, since 5 days ago, most in keeping with ongoing COVID pneumonitis. No large pleural effusion. 09/04 pt deceased
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lung opacity, Nausea, SARS-CoV-2 test positive, Ventilation/perfusion scan
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 CXR impression: Probable atelectatic changes in the left base. Otherwise no acute process is seen. 08/26 pt cc: Nausea, vomiting, fatigue exposure: unknown 08/28 pulm v/q impression: No definite perfusion abnormality to suggest significant pulmonary embolus. Small pulmonary emboli cannot be completely excluded. 09/01 CXR impression: New and large-volume parenchymal opacities within both lungs, RIGHT much worse than LEFT, since 5 days ago, most in keeping with ongoing COVID pneumonitis. No large pleural effusion. 09/04 pt deceased
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 CXR impression: Probable atelectatic changes in the left base. Otherwise no acute process is seen. 08/26 pt cc: Nausea, vomiting, fatigue exposure: unknown 08/28 pulm v/q impression: No definite perfusion abnormality to suggest significant pulmonary embolus. Small pulmonary emboli cannot be completely excluded. 09/01 CXR impression: New and large-volume parenchymal opacities within both lungs, RIGHT much worse than LEFT, since 5 days ago, most in keeping with ongoing COVID pneumonitis. No large pleural effusion. 09/04 pt deceased
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Nausea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/03 Janssen, dose #1 09/07 pt cc: chills, cough, diarrhea, nausea, rhinorrhea, vomiting, exposure: unknown 09/10 COVID swab, result: detected 09/10 SARS-COV-2 Variant Sequencing result: pending
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/03 Janssen, dose #1 09/07 pt cc: chills, cough, diarrhea, nausea, rhinorrhea, vomiting, exposure: unknown 09/10 COVID swab, result: detected 09/10 SARS-COV-2 Variant Sequencing result: pending
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Cough, Exposure to SARS-CoV-2
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/24, Pfizer, dose#1 04/14, Pfizer, dose #2 09/05 pt cc: myalgias, rhinorrhea, cough, fatigue, exposure: Cruise ship 09/10 COVID swab, result: detected 09/10 pt admit to ED cc: weakness/cough/body aches x 5 days dx: Coronavirus LOS: 1 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 CXR impression: No active disease.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/24, Pfizer, dose#1 04/14, Pfizer, dose #2 09/05 pt cc: myalgias, rhinorrhea, cough, fatigue, exposure: Cruise ship 09/10 COVID swab, result: detected 09/10 pt admit to ED cc: weakness/cough/body aches x 5 days dx: Coronavirus LOS: 1 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 CXR impression: No active disease.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/24, Pfizer, dose#1 04/14, Pfizer, dose #2 09/05 pt cc: myalgias, rhinorrhea, cough, fatigue, exposure: Cruise ship 09/10 COVID swab, result: detected 09/10 pt admit to ED cc: weakness/cough/body aches x 5 days dx: Coronavirus LOS: 1 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 CXR impression: No active disease.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/15 MODERNA, dose #1 05/13, MODERNA, dose #2 09/07 pt cc: cough, fever, headache, loss of taste or smell, nausea, sore throat exposure: unknown 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 COVID swab, result: detected
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/15 MODERNA, dose #1 05/13, MODERNA, dose #2 09/07 pt cc: cough, fever, headache, loss of taste or smell, nausea, sore throat exposure: unknown 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 COVID swab, result: detected
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/24, Moderna dose #1 02/11, Moderna, dose#2 09/08 pt cc: rhinorrhea, sore throat exposure: travelled 09/10 COVID swab, result: detected 09/10 SARS-COV-2 Variant Sequencing result: pending
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/24, Moderna dose #1 02/11, Moderna, dose#2 09/08 pt cc: rhinorrhea, sore throat exposure: travelled 09/10 COVID swab, result: detected 09/10 SARS-COV-2 Variant Sequencing result: pending
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Blood fibrinogen increased, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 01/30 COVID swab, result: not detected 05/18 COVID swab, result: not detected 02/02, Pfizer, dose #2 08/05 COVID swab, result: detected 08/06 pt cc: cough, diarrhea, fatigue, nausea, vomiting, fatigue, fever, loss of taste, myalgias, dyspnea, low o2 saturation, exposure: recently deceased spouse from COVID OR COPD 08/07-08/18 pt continue to have symptoms 0810 cxr impression: New bilateral pneumonia. 08/10 ED Admission dx: PNA 08/10 Medical admission dx: Bilat PNA 08/10 c-reative protein result: 11.076 08/11 procalcitonin result: 0.10 08/11 legionella result: negative 08/11 strep pneumoniae antigen result: negative 08/11 ESR 74 08/12 fibrinogen result: 602 08/12 DDIMER result: 0.57 0811 QUANTIFERON-TB result: negative 08/11 HIV result: non-reactive 08/11 SARS COV-2 IgG result: 0.20 08/12 ESR 35 08/12 fibrinogen result: 414 0812 DDIMER result: 0.43 08/14 ESR 31 08/14 fibrinogen result: 317 08/14 DDIMER result: 0.59 08/14 SARS-COVID-2 TOTAL AB SPIKE >25000 08/15 ESR 4 08/15 fibrinogen result: 321 08/15 DDIMER result: 0.57 08/16 fibrinogen result: 308 08/16 DDIMER result: 0.55 08/16 ESR 4 08/21 clinically resolved 08/26, Pfizer, dose #3
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Fatigue, Fibrin D dimer increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 01/30 COVID swab, result: not detected 05/18 COVID swab, result: not detected 02/02, Pfizer, dose #2 08/05 COVID swab, result: detected 08/06 pt cc: cough, diarrhea, fatigue, nausea, vomiting, fatigue, fever, loss of taste, myalgias, dyspnea, low o2 saturation, exposure: recently deceased spouse from COVID OR COPD 08/07-08/18 pt continue to have symptoms 0810 cxr impression: New bilateral pneumonia. 08/10 ED Admission dx: PNA 08/10 Medical admission dx: Bilat PNA 08/10 c-reative protein result: 11.076 08/11 procalcitonin result: 0.10 08/11 legionella result: negative 08/11 strep pneumoniae antigen result: negative 08/11 ESR 74 08/12 fibrinogen result: 602 08/12 DDIMER result: 0.57 0811 QUANTIFERON-TB result: negative 08/11 HIV result: non-reactive 08/11 SARS COV-2 IgG result: 0.20 08/12 ESR 35 08/12 fibrinogen result: 414 0812 DDIMER result: 0.43 08/14 ESR 31 08/14 fibrinogen result: 317 08/14 DDIMER result: 0.59 08/14 SARS-COVID-2 TOTAL AB SPIKE >25000 08/15 ESR 4 08/15 fibrinogen result: 321 08/15 DDIMER result: 0.57 08/16 fibrinogen result: 308 08/16 DDIMER result: 0.55 08/16 ESR 4 08/21 clinically resolved 08/26, Pfizer, dose #3
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: HIV test negative, Legionella test, Myalgia, Mycobacterium tuberculosis complex test negative, Nausea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 01/30 COVID swab, result: not detected 05/18 COVID swab, result: not detected 02/02, Pfizer, dose #2 08/05 COVID swab, result: detected 08/06 pt cc: cough, diarrhea, fatigue, nausea, vomiting, fatigue, fever, loss of taste, myalgias, dyspnea, low o2 saturation, exposure: recently deceased spouse from COVID OR COPD 08/07-08/18 pt continue to have symptoms 0810 cxr impression: New bilateral pneumonia. 08/10 ED Admission dx: PNA 08/10 Medical admission dx: Bilat PNA 08/10 c-reative protein result: 11.076 08/11 procalcitonin result: 0.10 08/11 legionella result: negative 08/11 strep pneumoniae antigen result: negative 08/11 ESR 74 08/12 fibrinogen result: 602 08/12 DDIMER result: 0.57 0811 QUANTIFERON-TB result: negative 08/11 HIV result: non-reactive 08/11 SARS COV-2 IgG result: 0.20 08/12 ESR 35 08/12 fibrinogen result: 414 0812 DDIMER result: 0.43 08/14 ESR 31 08/14 fibrinogen result: 317 08/14 DDIMER result: 0.59 08/14 SARS-COVID-2 TOTAL AB SPIKE >25000 08/15 ESR 4 08/15 fibrinogen result: 321 08/15 DDIMER result: 0.57 08/16 fibrinogen result: 308 08/16 DDIMER result: 0.55 08/16 ESR 4 08/21 clinically resolved 08/26, Pfizer, dose #3
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pneumonia, Procalcitonin normal, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 01/30 COVID swab, result: not detected 05/18 COVID swab, result: not detected 02/02, Pfizer, dose #2 08/05 COVID swab, result: detected 08/06 pt cc: cough, diarrhea, fatigue, nausea, vomiting, fatigue, fever, loss of taste, myalgias, dyspnea, low o2 saturation, exposure: recently deceased spouse from COVID OR COPD 08/07-08/18 pt continue to have symptoms 0810 cxr impression: New bilateral pneumonia. 08/10 ED Admission dx: PNA 08/10 Medical admission dx: Bilat PNA 08/10 c-reative protein result: 11.076 08/11 procalcitonin result: 0.10 08/11 legionella result: negative 08/11 strep pneumoniae antigen result: negative 08/11 ESR 74 08/12 fibrinogen result: 602 08/12 DDIMER result: 0.57 0811 QUANTIFERON-TB result: negative 08/11 HIV result: non-reactive 08/11 SARS COV-2 IgG result: 0.20 08/12 ESR 35 08/12 fibrinogen result: 414 0812 DDIMER result: 0.43 08/14 ESR 31 08/14 fibrinogen result: 317 08/14 DDIMER result: 0.59 08/14 SARS-COVID-2 TOTAL AB SPIKE >25000 08/15 ESR 4 08/15 fibrinogen result: 321 08/15 DDIMER result: 0.57 08/16 fibrinogen result: 308 08/16 DDIMER result: 0.55 08/16 ESR 4 08/21 clinically resolved 08/26, Pfizer, dose #3
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Streptococcus test negative, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/12, Pfizer, dose #1 01/30 COVID swab, result: not detected 05/18 COVID swab, result: not detected 02/02, Pfizer, dose #2 08/05 COVID swab, result: detected 08/06 pt cc: cough, diarrhea, fatigue, nausea, vomiting, fatigue, fever, loss of taste, myalgias, dyspnea, low o2 saturation, exposure: recently deceased spouse from COVID OR COPD 08/07-08/18 pt continue to have symptoms 0810 cxr impression: New bilateral pneumonia. 08/10 ED Admission dx: PNA 08/10 Medical admission dx: Bilat PNA 08/10 c-reative protein result: 11.076 08/11 procalcitonin result: 0.10 08/11 legionella result: negative 08/11 strep pneumoniae antigen result: negative 08/11 ESR 74 08/12 fibrinogen result: 602 08/12 DDIMER result: 0.57 0811 QUANTIFERON-TB result: negative 08/11 HIV result: non-reactive 08/11 SARS COV-2 IgG result: 0.20 08/12 ESR 35 08/12 fibrinogen result: 414 0812 DDIMER result: 0.43 08/14 ESR 31 08/14 fibrinogen result: 317 08/14 DDIMER result: 0.59 08/14 SARS-COVID-2 TOTAL AB SPIKE >25000 08/15 ESR 4 08/15 fibrinogen result: 321 08/15 DDIMER result: 0.57 08/16 fibrinogen result: 308 08/16 DDIMER result: 0.55 08/16 ESR 4 08/21 clinically resolved 08/26, Pfizer, dose #3
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 94yo male died on 9/19/2021 at hospital (community hospital) who had hx of cad, afib, hx of cva, htn, hld, bph, gerd, gout, chronic back/shoulder/knee pain. Pt had receive covid vaccines on 1/11/21 & 2/8/21. Likely pt's death not related to covid vaccines given pt's advanced age, comorbities & long timeframe between date of vaccines & date of death.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose# 1 02/06, Pfizer, dose #2 09/09 pt cc: chills, cough, fever, dyspnea, myalgias, exposure: unknown 09/11 COVID swab, result: detected
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose# 1 02/06, Pfizer, dose #2 09/09 pt cc: chills, cough, fever, dyspnea, myalgias, exposure: unknown 09/11 COVID swab, result: detected
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Facial pain, Pain in jaw, SARS-CoV-2 test positive, Scan abnormal
Clinical narrative: Narrative: 64-year-old gentleman with a history of chronic hypersensitivity pneumonitis), HTN, HLD, GERD, NIDDM2, MDD, and hx suicide attempt in 12/2019 via self-inflicted GSW to the head now s/p mandibular repair with Plastic Surgery with titanium plates presenting with a couple of weeks of left mandibular swelling & pain and progressive pain over this area and his chin for appx the past 6 days. Patient was in the process of being admitted to Plastics as scan showed a potential plate fracture though tested positive in the ED for COVID. Admitted to medicine unit for isolation (hospitalization NOT related to COVID). Received COVID Moderna vaccine March and April 2021. Remained COVID asymptomatic during hospitalization course and did not receive steroids, COVID therapeutics, or oxygen supplementation while hospitalized.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: Narrative: 64-year-old gentleman with a history of chronic hypersensitivity pneumonitis), HTN, HLD, GERD, NIDDM2, MDD, and hx suicide attempt in 12/2019 via self-inflicted GSW to the head now s/p mandibular repair with Plastic Surgery with titanium plates presenting with a couple of weeks of left mandibular swelling & pain and progressive pain over this area and his chin for appx the past 6 days. Patient was in the process of being admitted to Plastics as scan showed a potential plate fracture though tested positive in the ED for COVID. Admitted to medicine unit for isolation (hospitalization NOT related to COVID). Received COVID Moderna vaccine March and April 2021. Remained COVID asymptomatic during hospitalization course and did not receive steroids, COVID therapeutics, or oxygen supplementation while hospitalized.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  fBreakthrough Delta Variant COVID infection requiring hospitalization; discharged 9/4/21
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough Delta Variant COVID infection requiring hospitalization
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough COVID infection which increased the risk for pulmonary embolism which caused the patient to be hospitalized
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Breast mass, COVID-19, Chest X-ray normal, Dyspnoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series Q03/31, Pfizer, dose#1 04/31, Pfizer, dose #2 09/13 COVID swab, result: detected 09/13 pt admit to ED cc: SOB and productive cough dx: Covid infection LOS: 1 day 09/13 pt cc: SOB and productive cough exposure: unknown 09/13 CTA PE impression: Motion partly limits evaluation. No definite acute central pulmonary embolism. If there is high clinical suspicion of pulmonary embolism, consider venous Doppler sonogram. Left breast 1.8 cm nodular density could be correlated with physical exam/diagnostic mammogram. 09/13 CXR impression: Negative portable chest. 09/13 COVID-19 ANTIGEN (BINAX): not detected 09/13 DDIMER 1.03
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer decreased, Productive cough, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series Q03/31, Pfizer, dose#1 04/31, Pfizer, dose #2 09/13 COVID swab, result: detected 09/13 pt admit to ED cc: SOB and productive cough dx: Covid infection LOS: 1 day 09/13 pt cc: SOB and productive cough exposure: unknown 09/13 CTA PE impression: Motion partly limits evaluation. No definite acute central pulmonary embolism. If there is high clinical suspicion of pulmonary embolism, consider venous Doppler sonogram. Left breast 1.8 cm nodular density could be correlated with physical exam/diagnostic mammogram. 09/13 CXR impression: Negative portable chest. 09/13 COVID-19 ANTIGEN (BINAX): not detected 09/13 DDIMER 1.03
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Nasopharyngitis, SARS-CoV-2 test, SARS-CoV-2 test negative
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/08, Pfizer, dose #2 09/05 pt cc: exposure: unknown 09/1 pt admit to ED cc: cold symptoms dx: COVID 19 LOS: 1 day 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending 09/13 COVID-19 ANTIGEN BINAX: NOT detected 09/13 CXR impression: FINDINGS AND IMPRESSION: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: No dense consolidation or pleural effusion is identified. Bones; Within normal limits 09/16 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/08, Pfizer, dose #2 09/05 pt cc: exposure: unknown 09/1 pt admit to ED cc: cold symptoms dx: COVID 19 LOS: 1 day 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending 09/13 COVID-19 ANTIGEN BINAX: NOT detected 09/13 CXR impression: FINDINGS AND IMPRESSION: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: No dense consolidation or pleural effusion is identified. Bones; Within normal limits 09/16 clinically resolved
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Exposure to SARS-CoV-2, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/14, Moderna , dose #1 02/12, Moderna , dose #2 10/27, Moderna , dose #3 09/13 COVID swab, result: detected 09/13 SARS-COV-E Variant Sequencing result: pending 09/15 pt cc: fever, myalgis, rhinorrhea, cough, dyspnea exposure: traveling
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/14, Moderna , dose #1 02/12, Moderna , dose #2 10/27, Moderna , dose #3 09/13 COVID swab, result: detected 09/13 SARS-COV-E Variant Sequencing result: pending 09/15 pt cc: fever, myalgis, rhinorrhea, cough, dyspnea exposure: traveling
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray normal, Chills
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/21 Janssen, dose #1 08/17 COVID swab, result: not detected 09/03 CXR impression: No active disease. 09/08 pt cc: chills, cough, fever, headace, loss of taste or smell, myalgias, nausea, rhinorrhea, sore throat, vomiting, exposure: unknown 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/21 Janssen, dose #1 08/17 COVID swab, result: not detected 09/03 CXR impression: No active disease. 09/08 pt cc: chills, cough, fever, headace, loss of taste or smell, myalgias, nausea, rhinorrhea, sore throat, vomiting, exposure: unknown 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/21 Janssen, dose #1 08/17 COVID swab, result: not detected 09/03 CXR impression: No active disease. 09/08 pt cc: chills, cough, fever, headace, loss of taste or smell, myalgias, nausea, rhinorrhea, sore throat, vomiting, exposure: unknown 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Narrative: Third and booster dose of Moderna Covid Vaccine was administered as a full dose of 0.5ml instead of 0.25ml to patient. No adverse events were reported by patient during 15 minute observation period or after that time. Patient is not immunocompromised.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough Delta Variant COVID infection requiring hospitalization
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Dyspnoea, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020, Pfizer, dose #1 01/19/2021. Pfizer, dose #2 09/07 COVID swab, result: detected 09/07 SARS-COV-2 Variant Sequencing result: pending 10/16 COVID swab, result: not detected 09/03 pt cc: fever, dyspnea, rhinorrhea, diarrhea, vomiting exposure: unknown
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020, Pfizer, dose #1 01/19/2021. Pfizer, dose #2 09/07 COVID swab, result: detected 09/07 SARS-COV-2 Variant Sequencing result: pending 10/16 COVID swab, result: not detected 09/03 pt cc: fever, dyspnea, rhinorrhea, diarrhea, vomiting exposure: unknown
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Alcohol abuse, COVID-19, Myalgia, Nausea, Pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04 COVID swab, result: NOT detected 03/16, Pfizer, dose #1 04/05, Pfizer, dose #2 09/07 pt cc: myalgias exposure: unknown 09/08 COVID swab, result: detected 09/08 pt admit to ED cc: Body aches, nausea, vomiting since alcohol binge dx: mild Covid illness; alcohol abuse LOS: 1 day 09/08 TROPONON I: <0.016
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin I normal, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04 COVID swab, result: NOT detected 03/16, Pfizer, dose #1 04/05, Pfizer, dose #2 09/07 pt cc: myalgias exposure: unknown 09/08 COVID swab, result: detected 09/08 pt admit to ED cc: Body aches, nausea, vomiting since alcohol binge dx: mild Covid illness; alcohol abuse LOS: 1 day 09/08 TROPONON I: <0.016
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough COVID infection resulting in hospitalization
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chronic respiratory failure, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough covid-19 infection: Admitted with acute chronic hypoxic respiratory failure COVID-19 pneumonia
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate decreased, Blood fibrinogen increased, Blood gases abnormal, Blood lactate dehydrogenase increased, Blood pH normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04 ,Pfizer, dose #1 03/29, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: dyspnea, chills, cough, diarrhea ,fatigue exposure: unknown 08/11 LDH result 381 08/11 HBSAG result: nonreactive 08/11 CRP 5.885 08/11 CXR impression: Patchy bilateral airspace opacities concerning for pneumonia.. 08/12 ABG i-pH 7.44, i-PCO2 30.4, i-PO2 67 , i-HCO3 20.6 08/13 - 08/21 Pt symptoms continue 08/12 pt admit to ED dx: covid pneumonia with hypoxia LOS: 2 days 08/12 FIBRINOGEN result: 658 08/12 DDIMER result: 0.33 08/13 ESR result: 94 08/14 FIBRINOGEN result: 469 08/14 DDIMER result: 0.26 08/14 ESR result: 80
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04 ,Pfizer, dose #1 03/29, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: dyspnea, chills, cough, diarrhea ,fatigue exposure: unknown 08/11 LDH result 381 08/11 HBSAG result: nonreactive 08/11 CRP 5.885 08/11 CXR impression: Patchy bilateral airspace opacities concerning for pneumonia.. 08/12 ABG i-pH 7.44, i-PCO2 30.4, i-PO2 67 , i-HCO3 20.6 08/13 - 08/21 Pt symptoms continue 08/12 pt admit to ED dx: covid pneumonia with hypoxia LOS: 2 days 08/12 FIBRINOGEN result: 658 08/12 DDIMER result: 0.33 08/13 ESR result: 94 08/14 FIBRINOGEN result: 469 08/14 DDIMER result: 0.26 08/14 ESR result: 80
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Fatigue, Fibrin D dimer
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04 ,Pfizer, dose #1 03/29, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: dyspnea, chills, cough, diarrhea ,fatigue exposure: unknown 08/11 LDH result 381 08/11 HBSAG result: nonreactive 08/11 CRP 5.885 08/11 CXR impression: Patchy bilateral airspace opacities concerning for pneumonia.. 08/12 ABG i-pH 7.44, i-PCO2 30.4, i-PO2 67 , i-HCO3 20.6 08/13 - 08/21 Pt symptoms continue 08/12 pt admit to ED dx: covid pneumonia with hypoxia LOS: 2 days 08/12 FIBRINOGEN result: 658 08/12 DDIMER result: 0.33 08/13 ESR result: 94 08/14 FIBRINOGEN result: 469 08/14 DDIMER result: 0.26 08/14 ESR result: 80
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis B surface antigen negative, Hypoxia, Lung opacity, PCO2 decreased, PO2 decreased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04 ,Pfizer, dose #1 03/29, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: dyspnea, chills, cough, diarrhea ,fatigue exposure: unknown 08/11 LDH result 381 08/11 HBSAG result: nonreactive 08/11 CRP 5.885 08/11 CXR impression: Patchy bilateral airspace opacities concerning for pneumonia.. 08/12 ABG i-pH 7.44, i-PCO2 30.4, i-PO2 67 , i-HCO3 20.6 08/13 - 08/21 Pt symptoms continue 08/12 pt admit to ED dx: covid pneumonia with hypoxia LOS: 2 days 08/12 FIBRINOGEN result: 658 08/12 DDIMER result: 0.33 08/13 ESR result: 94 08/14 FIBRINOGEN result: 469 08/14 DDIMER result: 0.26 08/14 ESR result: 80
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/04 ,Pfizer, dose #1 03/29, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: dyspnea, chills, cough, diarrhea ,fatigue exposure: unknown 08/11 LDH result 381 08/11 HBSAG result: nonreactive 08/11 CRP 5.885 08/11 CXR impression: Patchy bilateral airspace opacities concerning for pneumonia.. 08/12 ABG i-pH 7.44, i-PCO2 30.4, i-PO2 67 , i-HCO3 20.6 08/13 - 08/21 Pt symptoms continue 08/12 pt admit to ED dx: covid pneumonia with hypoxia LOS: 2 days 08/12 FIBRINOGEN result: 658 08/12 DDIMER result: 0.33 08/13 ESR result: 94 08/14 FIBRINOGEN result: 469 08/14 DDIMER result: 0.26 08/14 ESR result: 80
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: 01/06, Pfizer, dose #1 01/26, Pfizer, dose #2 08/25 pt cc: diarrhea, loss ot tase or smell, exposure: unknown 09/08 COVID swab, result: detected
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Death, End stage renal disease
Clinical narrative: Narrative:  74yo male pt discharged from inpatient to home hospice with DISCHARGE DIAGNOSIS: Acute Renal Insufficiency, End Stage Renal Failure on 9/17/2021. Pt died at home in home hospice care on 9/19/2021. Pt had received covid vaccines on 2/14/201 & 3/14/2021. Death not related to vaccines.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough Delta Variant COVID infection requiring hospitalization
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough Delta Variant COVID infection requiring hospitalization
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  93yo male blind living in healthcare facility with h/o CHF, COPD, h/o PE, h/o DVT, Glaucoma, Macular degeneration, BPH, CAD, HTN, s/p myocardial infarct, HLD, degenerative lumbar disc. died on 5/25/2021. Pt had received covid vaccines on 1/6/21 and 1/27/21 from pharmacy. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 08/19 Janssen, dose #1 09/07 COVID swab, result: detected 09/07 pt cc: exposure: unknown 10/07 CXR impression: No active disease.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Fibrin D dimer increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/09, Pfizer, dose #2 02/16 PCR COVID 19 result: no detected 02/16 PCR FLU A result: negative 02/16 PCR FLU B result: negative 02/16 PCR RSV result: negative 05/30 08/23 COVID swab, result: NOT detected 08/06 pt cc: exposure: unknown 08/06 08/23 COVID swab, result: detected 08/06 CXR impression: No acute cardiopulmonary abnormality or change since 02/16/2021. 08/6-08/19 pt admitted to medicine from ED dx: covid pna & HRF 08/07 ESR result: 8 08/07 Fibrinogen result: 422 08/07 DDMINER result: 0.33 08/09 DDMINER result: 0.25 08/10 DDIMER result: 0.25 08/12 SAR-COV-2 Variant testing result: pending 08/14 Procalcitonin result: <0.05 08/14 CXR impression: No acute cardiopulmonary disease. 08/17 ESR result: 48 08/17 Fibrinogen result: 515 08/17 DDIMER result: 10.45 08/19 COVID swab, result: detected 08/18 ESR result: 37 08/18 Fibrinogen result: 491 08/18 DDIMER result: 1.15 08/19 ESR 53 08/20 pt was admitted to SNF 08/23 COVID swab, result: detected 08/23 CXR impression: Mild diffuse patchy opacities within lungs bilaterally, greatest in lower lungs. Findings are new/increased since the prior study. 08/27 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Lung opacity, Procalcitonin, Red blood cell sedimentation rate increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/09, Pfizer, dose #2 02/16 PCR COVID 19 result: no detected 02/16 PCR FLU A result: negative 02/16 PCR FLU B result: negative 02/16 PCR RSV result: negative 05/30 08/23 COVID swab, result: NOT detected 08/06 pt cc: exposure: unknown 08/06 08/23 COVID swab, result: detected 08/06 CXR impression: No acute cardiopulmonary abnormality or change since 02/16/2021. 08/6-08/19 pt admitted to medicine from ED dx: covid pna & HRF 08/07 ESR result: 8 08/07 Fibrinogen result: 422 08/07 DDMINER result: 0.33 08/09 DDMINER result: 0.25 08/10 DDIMER result: 0.25 08/12 SAR-COV-2 Variant testing result: pending 08/14 Procalcitonin result: <0.05 08/14 CXR impression: No acute cardiopulmonary disease. 08/17 ESR result: 48 08/17 Fibrinogen result: 515 08/17 DDIMER result: 10.45 08/19 COVID swab, result: detected 08/18 ESR result: 37 08/18 Fibrinogen result: 491 08/18 DDIMER result: 1.15 08/19 ESR 53 08/20 pt was admitted to SNF 08/23 COVID swab, result: detected 08/23 CXR impression: Mild diffuse patchy opacities within lungs bilaterally, greatest in lower lungs. Findings are new/increased since the prior study. 08/27 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory syncytial virus test negative, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/09, Pfizer, dose #2 02/16 PCR COVID 19 result: no detected 02/16 PCR FLU A result: negative 02/16 PCR FLU B result: negative 02/16 PCR RSV result: negative 05/30 08/23 COVID swab, result: NOT detected 08/06 pt cc: exposure: unknown 08/06 08/23 COVID swab, result: detected 08/06 CXR impression: No acute cardiopulmonary abnormality or change since 02/16/2021. 08/6-08/19 pt admitted to medicine from ED dx: covid pna & HRF 08/07 ESR result: 8 08/07 Fibrinogen result: 422 08/07 DDMINER result: 0.33 08/09 DDMINER result: 0.25 08/10 DDIMER result: 0.25 08/12 SAR-COV-2 Variant testing result: pending 08/14 Procalcitonin result: <0.05 08/14 CXR impression: No acute cardiopulmonary disease. 08/17 ESR result: 48 08/17 Fibrinogen result: 515 08/17 DDIMER result: 10.45 08/19 COVID swab, result: detected 08/18 ESR result: 37 08/18 Fibrinogen result: 491 08/18 DDIMER result: 1.15 08/19 ESR 53 08/20 pt was admitted to SNF 08/23 COVID swab, result: detected 08/23 CXR impression: Mild diffuse patchy opacities within lungs bilaterally, greatest in lower lungs. Findings are new/increased since the prior study. 08/27 clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Blood electrolytes abnormal, COVID-19, COVID-19 pneumonia, Death
Clinical narrative: Narrative:  Patient with PMHx ESRD/HD +  DM2 residing in long term care since 3/21 following Left BKA for gangrene/osteomyelitis. Tested positive for COVID-19 following complaints of malaise/fatigue. Transferred to acute care 8/5. Received dexamethasone and antibiotic therapy for sepsis and acute hypoxic respiratory failure due to COVID-19 pneumonia and possible secondary bacterial community acquired pneumonia. Many difficulties with fistula during dialysis making dialysis difficult. This resulted in multiple electrolyte abnormalities. Had an episode of SVT during dialysis requiring multiple doses of adenosine and amiodarone (bolus + infusion). After this event had severe hypotension and hypoxia associated with dialysis with very little dialysis able to occur. After discussion with family, decision made to transition to hospice care. Final cause of death acute hypoxic respiratory failure secondary to COVID-19 and end-stage renal disease.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dialysis related complication, Fatigue, Hypotension, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient with PMHx ESRD/HD +  DM2 residing in long term care since 3/21 following Left BKA for gangrene/osteomyelitis. Tested positive for COVID-19 following complaints of malaise/fatigue. Transferred to acute care 8/5. Received dexamethasone and antibiotic therapy for sepsis and acute hypoxic respiratory failure due to COVID-19 pneumonia and possible secondary bacterial community acquired pneumonia. Many difficulties with fistula during dialysis making dialysis difficult. This resulted in multiple electrolyte abnormalities. Had an episode of SVT during dialysis requiring multiple doses of adenosine and amiodarone (bolus + infusion). After this event had severe hypotension and hypoxia associated with dialysis with very little dialysis able to occur. After discussion with family, decision made to transition to hospice care. Final cause of death acute hypoxic respiratory failure secondary to COVID-19 and end-stage renal disease.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sepsis, Supraventricular tachycardia
Clinical narrative: Narrative:  Patient with PMHx ESRD/HD +  DM2 residing in long term care since 3/21 following Left BKA for gangrene/osteomyelitis. Tested positive for COVID-19 following complaints of malaise/fatigue. Transferred to acute care 8/5. Received dexamethasone and antibiotic therapy for sepsis and acute hypoxic respiratory failure due to COVID-19 pneumonia and possible secondary bacterial community acquired pneumonia. Many difficulties with fistula during dialysis making dialysis difficult. This resulted in multiple electrolyte abnormalities. Had an episode of SVT during dialysis requiring multiple doses of adenosine and amiodarone (bolus + infusion). After this event had severe hypotension and hypoxia associated with dialysis with very little dialysis able to occur. After discussion with family, decision made to transition to hospice care. Final cause of death acute hypoxic respiratory failure secondary to COVID-19 and end-stage renal disease.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 09/04 pt cc: chills, cough, diarrhea, fever, loss of taste or smell headache exposure: unknown 09/07 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05 Janssen, dose #1 09/04 pt cc: chills, cough, diarrhea, fever, loss of taste or smell headache exposure: unknown 09/07 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea
Clinical narrative: Narrative:  died 9/23; caregiver stated that on night if the 23rd, patient began to "breath funny" with very heavy breathing. She planned to send him to the hospital, but before ambulance could arrive he had already passed away.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, fever, headache, loss of taste or smell, Rhinorrhea exposure: unknown 09/08 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, fever, headache, loss of taste or smell, Rhinorrhea exposure: unknown 09/08 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: Covid infection following COVID vaccine series 04/16, Pfizer, dose #1 05/10 Pfizer, dose #2 09/04 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, dyspnea, sore throat , loss of taste or smell exposure: unknown 09/09 COVID swab, result: detected 09/14 SARS-COV-2 Variant Sequencing result: pending 09/17 clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative: Covid infection following COVID vaccine series 04/16, Pfizer, dose #1 05/10 Pfizer, dose #2 09/04 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, dyspnea, sore throat , loss of taste or smell exposure: unknown 09/09 COVID swab, result: detected 09/14 SARS-COV-2 Variant Sequencing result: pending 09/17 clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: Covid infection following COVID vaccine series 04/16, Pfizer, dose #1 05/10 Pfizer, dose #2 09/04 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, dyspnea, sore throat , loss of taste or smell exposure: unknown 09/09 COVID swab, result: detected 09/14 SARS-COV-2 Variant Sequencing result: pending 09/17 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/28/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 10/07/2021, Pfizer dose #3 09/07 cc: cough, diarrhea, fatigue, dyspnea exposure: unknown 09/09 COVID swab, result: detected
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/28/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 10/07/2021, Pfizer dose #3 09/07 cc: cough, diarrhea, fatigue, dyspnea exposure: unknown 09/09 COVID swab, result: detected
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Angiogram pulmonary abnormal, Blood gases abnormal, Blood pH normal, C-reactive protein increased
Clinical narrative: Narrative:  Patient received the Modern vaccine (first dose on 3/9/2021 and second dose on 4/6/2021). He developed upper respiratory symptoms on 9/2/2021 and presented to an Urgent Care, where he tested positive COVID-19. Symptoms worsened over the next 7 days and he presented to the ED on 9/10/2021. Biomarkers were significantly elevated (CRP 28.16, d-dimer 1.2, ferritin 390.9). CT angiogram was negative for PE but did reveal diffuse bilateral infiltrates. ABG revealed hypoxic respiratory failure (pH 7.44, pCO2 30, pO2 70) on 2LPM. Patient was deemed to not be a candidate for remdesivir due to acute on chronic renal failure. He was given tocilizumab 800mg (8mg/kg) IV x 1. He was initially admitted to ICU and placed on dexamethasone 6mg PO daily. He rapidly improved and was weaned to room air on 9/12/2021. He was discharged home on 9/14/2021.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Fibrin D dimer, Intensive care, Lung infiltration, PCO2 decreased
Clinical narrative: Narrative:  Patient received the Modern vaccine (first dose on 3/9/2021 and second dose on 4/6/2021). He developed upper respiratory symptoms on 9/2/2021 and presented to an Urgent Care, where he tested positive COVID-19. Symptoms worsened over the next 7 days and he presented to the ED on 9/10/2021. Biomarkers were significantly elevated (CRP 28.16, d-dimer 1.2, ferritin 390.9). CT angiogram was negative for PE but did reveal diffuse bilateral infiltrates. ABG revealed hypoxic respiratory failure (pH 7.44, pCO2 30, pO2 70) on 2LPM. Patient was deemed to not be a candidate for remdesivir due to acute on chronic renal failure. He was given tocilizumab 800mg (8mg/kg) IV x 1. He was initially admitted to ICU and placed on dexamethasone 6mg PO daily. He rapidly improved and was weaned to room air on 9/12/2021. He was discharged home on 9/14/2021.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: PO2 decreased, Respiratory failure, Respiratory symptom, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: Narrative:  Patient received the Modern vaccine (first dose on 3/9/2021 and second dose on 4/6/2021). He developed upper respiratory symptoms on 9/2/2021 and presented to an Urgent Care, where he tested positive COVID-19. Symptoms worsened over the next 7 days and he presented to the ED on 9/10/2021. Biomarkers were significantly elevated (CRP 28.16, d-dimer 1.2, ferritin 390.9). CT angiogram was negative for PE but did reveal diffuse bilateral infiltrates. ABG revealed hypoxic respiratory failure (pH 7.44, pCO2 30, pO2 70) on 2LPM. Patient was deemed to not be a candidate for remdesivir due to acute on chronic renal failure. He was given tocilizumab 800mg (8mg/kg) IV x 1. He was initially admitted to ICU and placed on dexamethasone 6mg PO daily. He rapidly improved and was weaned to room air on 9/12/2021. He was discharged home on 9/14/2021.